Stay updated on LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Sign up to get notified when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.

Latest updates to the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page footer revision label was updated from v3.5.3 to v3.5.4. This indicates a new revision of the page was published.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe Record History now shows a new revision entry (v3.5.3) replacing the previous v3.5.2, indicating an administrative update to the page's revision history.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded a new revision entry for version v3.5.2 and removed the previous v3.5.0 from the study record history.SummaryDifference0.1%

- Check70 days agoChange Detected- Added revision entry v3.5.0 - Removed revision entry v3.4.3SummaryDifference0.1%

- Check77 days agoChange DetectedRevision history shows v3.4.3 added and v3.4.2 removed.SummaryDifference0.1%

- Check105 days agoChange DetectedA new Revision: v3.4.2 is added and the older Revision: v3.4.1 notice is removed; these are metadata changes in the page history and do not affect study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.